This observation, supported by data presented here and also by proteomics studies in various human benign and cancer cell lines (Fig. S12), suggests that the additional phosphosites outside the N-terminal region are important for SMARCAD1 regulation (20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65). This evidence concerns the gene SMARCAD1 and cancer.